111 related articles for article (PubMed ID: 1479061)
41. Treatment of cocaine dependence and depression.
Rounsaville BJ
Biol Psychiatry; 2004 Nov; 56(10):803-9. PubMed ID: 15556126
[TBL] [Abstract][Full Text] [Related]
42. Designing drug efficacy trials in the treatment of cocaine abuse.
Satel SL; Kosten TR
J Nerv Ment Dis; 1991 Feb; 179(2):89-96. PubMed ID: 1990076
[TBL] [Abstract][Full Text] [Related]
43. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence.
Tennant FS; Tarver AL
NIDA Res Monogr; 1984; 55():159-63. PubMed ID: 6443373
[TBL] [Abstract][Full Text] [Related]
44. Quantitative urine levels of cocaine and other substances of abuse.
Wilkins JN
NIDA Res Monogr; 1997; 175():235-52. PubMed ID: 9467802
[TBL] [Abstract][Full Text] [Related]
45. Treatment of cocaine abuse: pharmacotherapy.
Kleber HD
Ciba Found Symp; 1992; 166():195-200; discussion 200-6. PubMed ID: 1638913
[TBL] [Abstract][Full Text] [Related]
46. Tricyclic antidepressants in the treatment of alcoholism and drug abuse.
Weiss RD; Mirin SM
J Clin Psychiatry; 1989 Jul; 50 Suppl():4-9; discussion 9-11. PubMed ID: 2661551
[TBL] [Abstract][Full Text] [Related]
47. Desipramine in the treatment of hypersomnolence following abrupt cessation of cocaine use.
Baxter LR
Am J Psychiatry; 1983 Nov; 140(11):1525-6. PubMed ID: 6625009
[TBL] [Abstract][Full Text] [Related]
48. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment.
Ellinwood EH; Lee TH
NIDA Res Monogr; 1997; 175():192-207. PubMed ID: 9467799
[No Abstract] [Full Text] [Related]
49. Clinical investigations of drug effects in women.
Mendelson JH; Mello NK
NIDA Res Monogr; 1986; 65():21-30. PubMed ID: 3090442
[No Abstract] [Full Text] [Related]
50. Management of clinical trials with new medications for cocaine dependence and abuse.
Kiev A
NIDA Res Monogr; 1997; 175():96-117. PubMed ID: 9467794
[TBL] [Abstract][Full Text] [Related]
51. Issues in classification in meta-analysis in substance abuse prevention research.
Hansen WB; Rose LA
NIDA Res Monogr; 1997; 170():183-201. PubMed ID: 9154258
[No Abstract] [Full Text] [Related]
52. Innovations in use of pharmacological treatments.
Giannini AJ
Am J Psychiatry; 1991 Aug; 148(8):1094-5. PubMed ID: 1853971
[No Abstract] [Full Text] [Related]
53. A note regarding meta-analysis of sequential trials with stopping for efficacy.
Senn S
Pharm Stat; 2014; 13(6):371-5. PubMed ID: 25296692
[TBL] [Abstract][Full Text] [Related]
54. Breaking the cycle of addiction.
Barnes DM
Science; 1988 Aug; 241(4869):1029-30. PubMed ID: 3413475
[No Abstract] [Full Text] [Related]
55. The treatment of chemical dependence.
Clark RJ
JAMA; 1989 Jun; 261(22):3239. PubMed ID: 2716149
[No Abstract] [Full Text] [Related]
56. Conference on meta-analysis in the design and monitoring of clinical trials.
Geller N; Freedman L; Lee YJ; DerSimonian R
Stat Med; 1999 Mar; 18(6):753-4. PubMed ID: 10204202
[No Abstract] [Full Text] [Related]
57. Behavioral strategies for the evaluation of new pharmacotherapies for drug abuse treatment.
Mello NK
NIDA Res Monogr; 1992; 119():150-4. PubMed ID: 1435971
[No Abstract] [Full Text] [Related]
58. Some comments on meta-analysis: discussion of "issues specific to evaluation of studies of periodontitis".
Kent R
J Periodontal Res; 1992 Jul; 27(4 Pt 2):445-7. PubMed ID: 1507034
[No Abstract] [Full Text] [Related]
59. Pharmacological approaches to cocaine dependence.
Kosten TR
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():70A-71A. PubMed ID: 1498999
[No Abstract] [Full Text] [Related]
60. Education section: Meta-analysis.
J Evid Based Med; 2009 Aug; 2(3):209-10. PubMed ID: 21349017
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
